455 related articles for article (PubMed ID: 28591554)
1. NLRP3 participates in the regulation of EMT in bleomycin-induced pulmonary fibrosis.
Tian R; Zhu Y; Yao J; Meng X; Wang J; Xie H; Wang R
Exp Cell Res; 2017 Aug; 357(2):328-334. PubMed ID: 28591554
[TBL] [Abstract][Full Text] [Related]
2. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T
J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of mTOR ameliorates bleomycin-induced pulmonary fibrosis by regulating epithelial-mesenchymal transition.
Han Q; Lin L; Zhao B; Wang N; Liu X
Biochem Biophys Res Commun; 2018 Jun; 500(4):839-845. PubMed ID: 29704504
[TBL] [Abstract][Full Text] [Related]
4. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH
BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658
[TBL] [Abstract][Full Text] [Related]
5. Analysis of TGF-β1- and drug-induced epithelial-mesenchymal transition in cultured alveolar epithelial cell line RLE/Abca3.
Takano M; Yamamoto C; Yamaguchi K; Kawami M; Yumoto R
Drug Metab Pharmacokinet; 2015 Feb; 30(1):111-8. PubMed ID: 25760538
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitor restores surfactant protein-C expression in alveolar-epithelial type II cells and attenuates bleomycin-induced pulmonary fibrosis in vivo.
Ota C; Yamada M; Fujino N; Motohashi H; Tando Y; Takei Y; Suzuki T; Takahashi T; Kamata S; Makiguchi T; Yamaya M; Kubo H
Exp Lung Res; 2015; 41(8):422-34. PubMed ID: 26151196
[TBL] [Abstract][Full Text] [Related]
7. Maresin 1 Inhibits Epithelial-to-Mesenchymal Transition in Vitro and Attenuates Bleomycin Induced Lung Fibrosis in Vivo.
Wang Y; Li R; Chen L; Tan W; Sun Z; Xia H; Li B; Yu Y; Gong J; Tang M; Ji Y; Yuan S; Shanglong Yao ; Shang Y
Shock; 2015 Nov; 44(5):496-502. PubMed ID: 26196843
[TBL] [Abstract][Full Text] [Related]
8. High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling.
Li LC; Li DL; Xu L; Mo XT; Cui WH; Zhao P; Zhou WC; Gao J; Li J
J Pharmacol Exp Ther; 2015 Sep; 354(3):302-9. PubMed ID: 26126535
[TBL] [Abstract][Full Text] [Related]
9. TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT).
Kasai H; Allen JT; Mason RM; Kamimura T; Zhang Z
Respir Res; 2005 Jun; 6(1):56. PubMed ID: 15946381
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-17 induces human alveolar epithelial to mesenchymal cell transition via the TGF-β1 mediated Smad2/3 and ERK1/2 activation.
Wang T; Liu Y; Zou JF; Cheng ZS
PLoS One; 2017; 12(9):e0183972. PubMed ID: 28873461
[TBL] [Abstract][Full Text] [Related]
11. Astragaloside IV modulates TGF-β1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis.
Qian W; Cai X; Qian Q; Zhang W; Wang D
J Cell Mol Med; 2018 Sep; 22(9):4354-4365. PubMed ID: 29971947
[TBL] [Abstract][Full Text] [Related]
12. NLRP3 inflammasome inhibition attenuates silica-induced epithelial to mesenchymal transition (EMT) in human bronchial epithelial cells.
Li X; Yan X; Wang Y; Wang J; Zhou F; Wang H; Xie W; Kong H
Exp Cell Res; 2018 Jan; 362(2):489-497. PubMed ID: 29258746
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen sulfide attenuates epithelial-mesenchymal transition of human alveolar epithelial cells.
Fang LP; Lin Q; Tang CS; Liu XM
Pharmacol Res; 2010 Apr; 61(4):298-305. PubMed ID: 19913099
[TBL] [Abstract][Full Text] [Related]
14. Betanin protects against bleomycin-induced pulmonary fibrosis by regulating the NLRP3/IL-1β/TGF-β1 pathway-mediated epithelial-to-mesenchymal transition.
Abd Elrazik NA; Helmy SA
Food Funct; 2024 Jan; 15(1):284-294. PubMed ID: 38083874
[TBL] [Abstract][Full Text] [Related]
15. Paricalcitol attenuates TGF-β1-induced phenotype transition of human peritoneal mesothelial cells (HPMCs) via modulation of oxidative stress and NLRP3 inflammasome.
Ko J; Kang HJ; Kim DA; Ryu ES; Yu M; Lee H; Lee HK; Ryu HM; Park SH; Kim YL; Kang DH
FASEB J; 2019 Feb; 33(2):3035-3050. PubMed ID: 30354670
[TBL] [Abstract][Full Text] [Related]
16. Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation.
Guan R; Wang X; Zhao X; Song N; Zhu J; Wang J; Wang J; Xia C; Chen Y; Zhu D; Shen L
Sci Rep; 2016 Oct; 6():35696. PubMed ID: 27774992
[TBL] [Abstract][Full Text] [Related]
17. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.
Ji Y; Dou YN; Zhao QW; Zhang JZ; Yang Y; Wang T; Xia YF; Dai Y; Wei ZF
Acta Pharmacol Sin; 2016 Jun; 37(6):794-804. PubMed ID: 27133302
[TBL] [Abstract][Full Text] [Related]
18. Nrf2 inhibits epithelial-mesenchymal transition by suppressing snail expression during pulmonary fibrosis.
Zhou W; Mo X; Cui W; Zhang Z; Li D; Li L; Xu L; Yao H; Gao J
Sci Rep; 2016 Dec; 6():38646. PubMed ID: 27982105
[TBL] [Abstract][Full Text] [Related]
19. Role of insulin like growth factor axis in the bleomycin induced lung injury in rats.
Kotarkonda LK; Kulshrestha R; Ravi K
Exp Mol Pathol; 2017 Feb; 102(1):86-96. PubMed ID: 28077319
[TBL] [Abstract][Full Text] [Related]
20. CXCL9 Regulates TGF-β1-Induced Epithelial to Mesenchymal Transition in Human Alveolar Epithelial Cells.
O'Beirne SL; Walsh SM; Fabre A; Reviriego C; Worrell JC; Counihan IP; Lumsden RV; Cramton-Barnes J; Belperio JA; Donnelly SC; Boylan D; Marchal-Sommé J; Kane R; Keane MP
J Immunol; 2015 Sep; 195(6):2788-96. PubMed ID: 26268659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
